These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36550079)

  • 21. Dendrimer-Peptide Conjugates for Effective Blockade of the Interactions between SARS-CoV-2 Spike Protein and Human ACE2 Receptor.
    Jeong WJ; Bu J; Mickel P; Han Y; Rawding PA; Wang J; Kang H; Hong H; Král P; Hong S
    Biomacromolecules; 2023 Jan; 24(1):141-149. PubMed ID: 36562668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
    Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosensor-based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose.
    Yu W; Yi SZ; Jiang CY; Guan JW; Xue R; Zhang XX; Zeng T; Tang H; Chen W; Han B
    Biomed Chromatogr; 2024 Oct; 38(10):e5987. PubMed ID: 39126351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational Design of 25-mer Peptide Binders of SARS-CoV-2.
    Sitthiyotha T; Chunsrivirot S
    J Phys Chem B; 2020 Dec; 124(48):10930-10942. PubMed ID: 33200935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atomistic insight into the essential binding event of ACE2-derived peptides to the SARS-CoV-2 spike protein.
    Sarto C; Florez-Rueda S; Arrar M; Hackenberger CPR; Lauster D; Di Lella S
    Biol Chem; 2022 Apr; 403(5-6):615-624. PubMed ID: 35357791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
    Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I
    Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular dynamic simulation reveals spider antimicrobial peptide Latarcin-1 and human eosinophil cationic protein as peptide inhibitors of SARS-CoV-2 variants.
    Cao C; Mehmood A; Li D
    J Biomol Struct Dyn; 2024 Jul; 42(11):5858-5868. PubMed ID: 37938133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure/Function Analysis of Truncated Amino-Terminal ACE2 Peptide Analogs That Bind to SARS-CoV-2 Spike Glycoprotein.
    Mackin RT; Edwards JV; Atuk EB; Beltrami N; Condon BD; Jayawickramarajah J; French AD
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corilagin and 1,3,6-Tri-
    Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
    Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD-ACE2 Interaction.
    Fernandez-Fuentes N; Molina R; Oliva B
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
    Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
    F1000Res; 2020; 9():576. PubMed ID: 32802318
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular interactions between perlecan LG3 and the SARS-CoV-2 spike protein receptor binding domain.
    Gressett TE; Hossen ML; Talkington G; Volic M; Perez H; Tiwari PB; Chapagain P; Bix G
    Protein Sci; 2024 Jan; 33(1):e4843. PubMed ID: 37996967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2.
    Li HY; Gao N; Liu CY; Liu XL; Wu F; Dai N; Han J; Li QY
    Front Immunol; 2022; 13():918731. PubMed ID: 35874670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.